Published in Circ J on August 01, 2005
Bias in observational studies of prevalent users: lessons for comparative effectiveness research from a meta-analysis of statins. Am J Epidemiol (2012) 1.76
Risk factor reduction in progression of angiographic coronary artery disease. Arch Med Sci (2012) 1.08
Effects of atorvastatin on serum lipids, serum inflammation and plaque morphology in patients with stable atherosclerotic plaques. Exp Ther Med (2012) 0.80
The Prevalence of Risk Factors of Coronary Artery Disease in the Patients who Underwent Coronary Artery Bypass Graft, Shiraz, Iran: Suggesting a Model. Int Cardiovasc Res J (2014) 0.75
Secondary prevention of major cerebrovascular events with seven different statins: a multi-treatment meta-analysis. Drug Des Devel Ther (2017) 0.75
Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial. Lancet (2006) 7.01
Prevalence and clinical outcome of polyvascular atherosclerotic disease in patients undergoing coronary intervention. Circ J (2012) 2.62
Incidence and clinical impact of stent fracture after everolimus-eluting stent implantation. Circ Cardiovasc Interv (2012) 2.61
In-hospital outcomes of contemporary percutaneous coronary intervention in patients with chronic total occlusion insights from the J-CTO Registry (Multicenter CTO Registry in Japan). JACC Cardiovasc Interv (2010) 2.36
A multicenter randomized comparison of paclitaxel-coated balloon catheter with conventional balloon angioplasty in patients with bare-metal stent restenosis and drug-eluting stent restenosis. Am Heart J (2013) 2.19
Accuracy in measurement of distance using limited cone-beam computerized tomography. Int J Oral Maxillofac Implants (2004) 2.14
Predicting successful guidewire crossing through chronic total occlusion of native coronary lesions within 30 minutes: the J-CTO (Multicenter CTO Registry in Japan) score as a difficulty grading and time assessment tool. JACC Cardiovasc Interv (2011) 2.12
Very late stent thrombosis and late target lesion revascularization after sirolimus-eluting stent implantation: five-year outcome of the j-Cypher Registry. Circulation (2011) 2.02
An MRI-based atlas and database of the developing mouse brain. Neuroimage (2010) 1.99
Primary retroperitoneal neoplasms: CT and MR imaging findings with anatomic and pathologic diagnostic clues. Radiographics (2003) 1.90
Quantitative diffusion tensor tractography of the motor and sensory tract in children with cerebral palsy. Dev Med Child Neurol (2010) 1.87
Bare metal stent thrombosis and in-stent neoatherosclerosis. Circ Cardiovasc Interv (2012) 1.82
Classification and clinical impact of restenosis after femoropopliteal stenting. J Am Coll Cardiol (2012) 1.74
Effectiveness of paclitaxel-eluting balloon catheter in patients with sirolimus-eluting stent restenosis. JACC Cardiovasc Interv (2011) 1.70
Functional variation in LGALS2 confers risk of myocardial infarction and regulates lymphotoxin-alpha secretion in vitro. Nature (2004) 1.68
Kidney function: glomerular filtration rate measurement with MR renography in patients with cirrhosis. Radiology (2011) 1.66
Primary percutaneous coronary intervention for acute myocardial infarction in the elderly aged ≥75 years. Catheter Cardiovasc Interv (2011) 1.64
18F-FDG small-animal PET for monitoring the therapeutic effect of CT-guided radiofrequency ablation on implanted VX2 lung tumors in rabbits. J Nucl Med (2006) 1.62
Percutaneous recanalization of chronically occluded coronary arteries: a consensus document: part I. Circulation (2005) 1.60
Long-term prognosis of patients with Kawasaki disease complicated by giant coronary aneurysms: a single-institution experience. Circulation (2011) 1.58
Symmetrical central tegmental tract (CTT) hyperintense lesions on magnetic resonance imaging in children. Eur Radiol (2008) 1.58
Impact of multiple and long sirolimus-eluting stent implantation on 3-year clinical outcomes in the j-Cypher Registry. JACC Cardiovasc Interv (2010) 1.58
Multiple gastric ruptures caused by blunt abdominal trauma: report of a case. Surg Today (2002) 1.57
Randomized comparison of the Nobori biolimus A9-eluting stent with the sirolimus-eluting stent in patients with stenosis in native coronary arteries. Catheter Cardiovasc Interv (2011) 1.54
Impact of J-CTO score on procedural outcome and target lesion revascularisation after percutaneous coronary intervention for chronic total occlusion: a substudy of the J-CTO Registry (Multicentre CTO Registry in Japan). EuroIntervention (2016) 1.53
Long-term results of the S.M.A.R.T. Control(TM) stent for superficial femoral artery lesions, J-SMART registry. Circ J (2011) 1.52
Long-term clinical and angiographic follow-up after coronary stent placement in native coronary arteries. Circulation (2002) 1.51
Prevalence of metabolic syndrome in the general Japanese population in 2000. J Atheroscler Thromb (2006) 1.50
Antiplatelet therapy and stent thrombosis after sirolimus-eluting stent implantation. Circulation (2009) 1.49
Sirolimus-eluting stent versus balloon angioplasty for sirolimus-eluting stent restenosis: Insights from the j-Cypher Registry. Circulation (2010) 1.49
Seven-year clinical outcomes of unprotected left main coronary artery stenting with drug-eluting stent and bare-metal stent. Circ J (2013) 1.48
Efficacy of fluid assessment based on intrathoracic impedance monitoring in patients with systolic heart failure. Circ J (2010) 1.48
Impact of cilostazol after endovascular treatment for infrainguinal disease in patients with critical limb ischemia. J Vasc Surg (2011) 1.48
Percutaneous recanalization of chronically occluded coronary arteries: a consensus document: part II. Circulation (2005) 1.46
Restenosis after stent implantation for superficial femoral artery disease in patients treated with cilostazol. Catheter Cardiovasc Interv (2011) 1.46
Primary angioplasty of unprotected left main coronary artery for acute anterolateral myocardial infarction. J Invasive Cardiol (2004) 1.45
Apparent diffusion coefficient values in peripheral and transition zones of the prostate: comparison between normal and malignant prostatic tissues and correlation with histologic grade. J Magn Reson Imaging (2008) 1.43
Long-term outcome of transcatheter polytetrafluoroethylene-covered stent implantation in a giant coronary aneurysm of a child with Kawasaki disease. Catheter Cardiovasc Interv (2012) 1.42
Coronary angioplasty reduces free wall rupture and improves mortality and morbidity of acute myocardial infarction. J Invasive Cardiol (2004) 1.41
Low systolic blood pressure on admission predicts mortality in patients with acute decompensated heart failure due to moderate to severe aortic stenosis. Circ J (2014) 1.40
Optimal treatment of recurrent restenosis lesions after drug-eluting stent implantation for in-stent restenosis lesions. EuroIntervention (2013) 1.38
Pathological analyses of long-term intracoronary Palmaz-Schatz stenting; Is its efficacy permanent? Cardiovasc Pathol (2004) 1.36
HMGB1 expression by activated vascular smooth muscle cells in advanced human atherosclerosis plaques. Cardiovasc Pathol (2007) 1.31
Tissue gadolinium deposition in hepatorenally impaired rats exposed to Gd-EOB-DTPA: evaluation with inductively coupled plasma mass spectrometry (ICP-MS). Radiol Med (2015) 1.30
Sequential follow-up results of catheter intervention for coronary artery lesions after Kawasaki disease: quantitative coronary artery angiography and intravascular ultrasound imaging study. Circulation (2002) 1.30
Prostate cancer: relationships between postbiopsy hemorrhage and tumor detectability at MR diagnosis. Radiology (2008) 1.29
SNPs in BRAP associated with risk of myocardial infarction in Asian populations. Nat Genet (2009) 1.29
Prognostic utility of T-wave alternans in a real-world population of patients with left ventricular dysfunction: the PREVENT-SCD study. Clin Res Cardiol (2011) 1.20
Chitosan capsules for colon-specific drug delivery: enhanced localization of 5-aminosalicylic acid in the large intestine accelerates healing of TNBS-induced colitis in rats. J Control Release (2002) 1.18
Ratio of serum n-3 to n-6 polyunsaturated fatty acids and the incidence of major adverse cardiac events in patients undergoing percutaneous coronary intervention. Circ J (2011) 1.18
P-glycoprotein restricts the penetration of oseltamivir across the blood-brain barrier. Drug Metab Dispos (2007) 1.17
Direct transformation from amorphous to crystalline calcium phosphate facilitated by motif-programmed artificial proteins. Proc Natl Acad Sci U S A (2008) 1.17
Incidence, risk factors, and clinical sequelae of angiographic peri-stent contrast staining after sirolimus-eluting stent implantation. Circulation (2011) 1.13
Aspiration thrombectomy of a massive thrombotic embolus in acute myocardial infarction caused by coronary embolism. Int Heart J (2007) 1.12
Percutaneous recanalization of chronically occluded coronary arteries: procedural techniques, devices, and results. Catheter Cardiovasc Interv (2005) 1.12
Liliequist membrane: three-dimensional constructive interference in steady state MR imaging. Radiology (2003) 1.12
Mid-term clinical outcome and predictors of vessel patency after femoropopliteal stenting with self-expandable nitinol stent. J Vasc Surg (2010) 1.09
Frequency and risk factors of various complications after computed tomography-guided radiofrequency ablation of lung tumors. Cardiovasc Intervent Radiol (2007) 1.09
Feasibility of the Inoue single-branched stent-graft implantation for thoracic aortic aneurysm or dissection involving the left subclavian artery: short- to medium-term results in 17 patients. J Vasc Surg (2005) 1.08
Very long-term (15 to 20 years) clinical and angiographic outcome after coronary bare metal stent implantation. Circ Cardiovasc Interv (2010) 1.08
Asymptomatic microbleeds in moyamoya disease: T2*-weighted gradient-echo magnetic resonance imaging study. J Neurosurg (2005) 1.07
Fluorine-18-fluorodeoxyglucose positron emission tomography for assessment of patients with unresectable recurrent or metastatic lung cancers after CT-guided radiofrequency ablation: preliminary results. Ann Nucl Med (2006) 1.06
Creation and X-ray structure analysis of the tumor necrosis factor receptor-1-selective mutant of a tumor necrosis factor-alpha antagonist. J Biol Chem (2007) 1.06
Dynamic contrast-enhanced magnetic resonance imaging of abdominal solid organ and major vessel: comparison of enhancement effect between Gd-EOB-DTPA and Gd-DTPA. J Magn Reson Imaging (2009) 1.05
Long-term (three-year) outcomes after stenting of unprotected left main coronary artery stenosis in patients with normal left ventricular function. Am J Cardiol (2003) 1.03
Age-related and zonal anatomical changes of apparent diffusion coefficient values in normal human prostatic tissues. J Magn Reson Imaging (2008) 1.03
Serum lipid survey and its recent trend in the general Japanese population in 2000. J Atheroscler Thromb (2005) 1.03
Benign or malignant?: differentiating breast lesions with computed tomography attenuation values on dynamic computed tomography mammography. J Comput Assist Tomogr (2005) 1.02
Incidence and risk factors of late target lesion revascularization after sirolimus-eluting stent implantation (3-year follow-up of the j-Cypher Registry). Am J Cardiol (2010) 1.00
Modulation of intestinal P-glycoprotein function by polyethylene glycols and their derivatives by in vitro transport and in situ absorption studies. Int J Pharm (2006) 0.99
Comparison of three-year clinical outcomes after sirolimus-eluting stent implantation among insulin-treated diabetic, non-insulin-treated diabetic, and non-diabetic patients from j-Cypher registry. Am J Cardiol (2011) 0.99
Progranulin expression in advanced human atherosclerotic plaque. Atherosclerosis (2009) 0.98
Corticospinal tract localization: integration of diffusion-tensor tractography at 3-T MR imaging with intraoperative white matter stimulation mapping--preliminary results. Radiology (2006) 0.96
Successful treatment of primary cardiac lymphoma with atrioventricular nodal block. Int Heart J (2005) 0.96
Modulation of intestinal P-glycoprotein function by cremophor EL and other surfactants by an in vitro diffusion chamber method using the isolated rat intestinal membranes. J Pharm Sci (2004) 0.95
CCN1 knockdown suppresses neointimal hyperplasia in a rat artery balloon injury model. Arterioscler Thromb Vasc Biol (2008) 0.95
Long-term outcomes after percutaneous coronary intervention for chronic total occlusion (from the CREDO-Kyoto registry cohort-2). Am J Cardiol (2013) 0.95
MR contrast of ferritin and hemosiderin in the brain: comparison among gradient-echo, conventional spin-echo and fast spin-echo sequences. Eur J Radiol (2003) 0.95
Radiofrequency ablated lesion in the normal porcine lung: long-term follow-up with MRI and pathology. Cardiovasc Intervent Radiol (2005) 0.95
Optical coherence tomography findings in lesions after sirolimus-eluting stent implantation with peri-stent contrast staining. Circ Cardiovasc Interv (2012) 0.95
Different signal intensities between intra- and extracranial components in jugular foramen meningioma: an enigma. AJNR Am J Neuroradiol (2005) 0.95
The development and characteristics of novel microneedle arrays fabricated from hyaluronic acid, and their application in the transdermal delivery of insulin. J Control Release (2012) 0.95
Diffusion-tensor fiber tractography: intraindividual comparison of 3.0-T and 1.5-T MR imaging. Radiology (2006) 0.94
Comparison of 3.0- and 1.5-T three-dimensional time-of-flight MR angiography in moyamoya disease: preliminary experience. Radiology (2006) 0.94
Prostate cancer detection in patients with total serum prostate-specific antigen levels of 4-10 ng/mL: diagnostic efficacy of diffusion-weighted imaging, dynamic contrast-enhanced MRI, and T2-weighted imaging. AJR Am J Roentgenol (2011) 0.93
Clinical features and genetic analysis of autosomal recessive hypercholesterolemia. J Clin Endocrinol Metab (2003) 0.93
Late adverse events after implantation of sirolimus-eluting stent and bare-metal stent: long-term (5-7 years) follow-up of the Coronary Revascularization Demonstrating Outcome study-Kyoto registry Cohort-2. Circ Cardiovasc Interv (2014) 0.92
Hepatic hemangiomas: evaluation of enhancement patterns at dynamic MRI with gadoxetate disodium. AJR Am J Roentgenol (2011) 0.92
Functional expression of metabotropic GABAB receptors in primary cultures of astrocytes from rat cerebral cortex. Biochem Biophys Res Commun (2006) 0.91
Radiofrequency ablation and immunostimulant OK-432: combination therapy enhances systemic antitumor immunity for treatment of VX2 lung tumors in rabbits. Radiology (2013) 0.91
A uniqe antilipidemic drug--probucol. J Atheroscler Thromb (2008) 0.91
Variation in synergistic activity by flavone and its related compounds on the increased susceptibility of various strains of methicillin-resistant Staphylococcus aureus to beta-lactam antibiotics. Int J Antimicrob Agents (2004) 0.91